A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
AstraZeneca asks court to block former Investor Relations VP from working at GSK due to noncompete agreement the VP signed in 2021; agreement prevents the VP from facilitating competition for six months
Published:
August 17, 2022
by FiercePharma
|
GSK and IQVIA create Vaccine Track platform that allows public health officials, industry leaders to follow vaccination trends, uptake in US; platform tracks vaccinations trends across multiple vaccines, shows differences based on demographics
Published:
August 11, 2022
by FiercePharma
|
23ANDME HOLDING CO. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results
of Operations
Published:
August 09, 2022
by Edgar Glimpses
|
ZENTALIS PHARMACEUTICALS, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results
of Operations.
Published:
August 09, 2022
by Edgar Glimpses
|
Royalty Pharma buys royalty rights to GSK’s Trelegy Ellipta fluticasone furoate, umeclidinium, vilanterol from Theravance Respiratory for US$1.6B; Trelegy treats chronic obstructive pulmonary disease and asthma, had 2021 sales of US$1.7B
Published:
July 19, 2022
by SeeNews Pharmaceuticals
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count